Publicacións en colaboración con investigadores/as de University of California Davis Medical Center (1)

2019

  1. An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

    Lung Cancer, Vol. 136, pp. 74-79